[Prolonged intra-arterial chemotherapy with association of antimitotics and radiotherapy in inoperable tumors of the oro-cervico-facial region].
D000230:Adenocarcinoma / Q000628:therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D004428:Ear Neoplasms / Q000628:therapy*; D005153:Facial Neoplasms / Q000628:therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008545:Melanoma / Q000628:therapy; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000628:therapy*; D009669:Nose Neoplasms / Q000628:therapy*; D010255:Paranasal Sinus Neoplasms / Q000628:therapy*; D011882:Radiotherapy, High-Energy; D012509:Sarcoma / Q000628:therapy
D000970:Antineoplastic Agents
Chemioterapia intrarteriosa prolungata con associazione di antimitotici e radioterapia nei tumori inoperabili del distretto orocervico facciale.